The need for sex-specific precision biomarkers for antiplatelet therapies.
Publication
, Journal Article
Friede, K; Voora, D
Published in: Future Cardiol
September 2017
Duke Scholars
Published In
Future Cardiol
DOI
EISSN
1744-8298
Publication Date
September 2017
Volume
13
Issue
5
Start / End Page
419 / 422
Location
England
Related Subject Headings
- Cardiovascular System & Hematology
- 3201 Cardiovascular medicine and haematology
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Friede, K., & Voora, D. (2017). The need for sex-specific precision biomarkers for antiplatelet therapies. Future Cardiol, 13(5), 419–422. https://doi.org/10.2217/fca-2017-0043
Friede, Kevin, and Deepak Voora. “The need for sex-specific precision biomarkers for antiplatelet therapies.” Future Cardiol 13, no. 5 (September 2017): 419–22. https://doi.org/10.2217/fca-2017-0043.
Friede K, Voora D. The need for sex-specific precision biomarkers for antiplatelet therapies. Future Cardiol. 2017 Sep;13(5):419–22.
Friede, Kevin, and Deepak Voora. “The need for sex-specific precision biomarkers for antiplatelet therapies.” Future Cardiol, vol. 13, no. 5, Sept. 2017, pp. 419–22. Pubmed, doi:10.2217/fca-2017-0043.
Friede K, Voora D. The need for sex-specific precision biomarkers for antiplatelet therapies. Future Cardiol. 2017 Sep;13(5):419–422.
Published In
Future Cardiol
DOI
EISSN
1744-8298
Publication Date
September 2017
Volume
13
Issue
5
Start / End Page
419 / 422
Location
England
Related Subject Headings
- Cardiovascular System & Hematology
- 3201 Cardiovascular medicine and haematology
- 1102 Cardiorespiratory Medicine and Haematology